MTOR and neoplasm: Overactivated HER2 signaling results in increased HIF-1α and VEGF expression, which in turn activate the downstream kinase FKBP-rapamycin-associated protein (FRAP), therefore contributing to tumor progression by mediating angiogenesis and metabolic adaptation (221).